Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$307M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$294M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$246M |
| 4 |
Costco
COST
|
+$225M |
| 5 |
Lyft
LYFT
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferguson
FERG
|
+$692M |
| 2 |
Linde
LIN
|
+$624M |
| 3 |
Medtronic
MDT
|
+$527M |
| 4 |
Goldman Sachs
GS
|
+$340M |
| 5 |
Microsoft
MSFT
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.24% |
| 2 | Healthcare | 13.3% |
| 3 | Financials | 12.52% |
| 4 | Consumer Discretionary | 10.81% |
| 5 | Communication Services | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDNW
3476
RideNow Group
RDNW
$248M
| $827K | ﹤0.01% |
20,427
+7,751
| +61% | +$299K |
|
|
ONTF
3477
DELISTED
ON24
ONTF
| $825K | ﹤0.01% |
23,256
+139
| +0.6% | +$5.43K |
|
3478
James Hardie Industries
JHX
$17.9B
| $817K | ﹤0.01% |
23,871
+1,055
| +5% | +$35.4K |
|
3479
Identive
INVE
$64.1M
| $815K | ﹤0.01% |
+47,939
| New | +$724K |
|
3480
National Bankshares
NKSH
$271M
| $811K | ﹤0.01% |
23,150
-17,636
| -43% | -$622K |
|
3481
Full House Resorts
FLL
$83.5M
| $810K | ﹤0.01% |
81,473
+64,994
| +394% | +$629K |
|
3482
AquaBounty Technologies
AQB
$7.72M
| $808K | ﹤0.01% |
7,541
+5,976
| +382% | +$686K |
|
3483
Treace Medical Concepts
TMCI
$293M
| $808K | ﹤0.01% |
+25,865
| New | +$823K |
|
3484
Fortress Biotech
FBIO
$91.4M
| $807K | ﹤0.01% |
15,064
-248
| -2% | -$15K |
|
|
AMPE
3485
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $807K | ﹤0.01% |
1,610
+1,258
| +357% | +$676K |
|
|
USX
3486
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $805K | ﹤0.01% |
93,550
+6,349
| +7% | +$67.5K |
|
3487
Provident Financial
PROV
$113M
| $803K | ﹤0.01% |
46,509
-15,989
| -26% | -$269K |
|
|
OMIC
3488
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $801K | ﹤0.01% |
+971
| New | +$753K |
|
|
VEI
3489
DELISTED
Vine Energy Inc.
VEI
| $800K | ﹤0.01% |
+51,262
| New | +$705K |
|
3490
Comp X International
CIX
$386M
| $797K | ﹤0.01% |
38,382
-1,901
| -5% | -$41.8K |
|
3491
Aemetis
AMTX
$126M
| $793K | ﹤0.01% |
+70,984
| New | +$1.12M |
|
3492
Rush Enterprises Class B
RUSHB
$9.18B
| $791K | ﹤0.01% |
31,115
-931
| -3% | -$26.7K |
|
3493
AMES National
ATLO
$281M
| $790K | ﹤0.01% |
32,243
-26,352
| -45% | -$666K |
|
3494
Invesco S&P 500 High Beta ETF
SPHB
$956M
| $787K | ﹤0.01% |
+10,420
| New | +$773K |
|
3495
CorMedix
CRMD
$639M
| $786K | ﹤0.01% |
114,711
+19,845
| +21% | +$158K |
|
3496
WisdomTree International MidCap Dividend Fund
DIM
$169M
| $786K | ﹤0.01% |
11,594
+2,206
| +23% | +$153K |
|
3497
Atlanticus Holdings
ATLC
$1.48B
| $784K | ﹤0.01% |
19,736
-109
| -0.5% | -$3.82K |
|
|
NBEV
3498
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
| $780K | ﹤0.01% |
349,791
+47,036
| +16% | +$110K |
|
3499
Dianthus Therapeutics
DNTH
$6.13B
| $777K | ﹤0.01% |
4,964
+809
| +19% | +$149K |
|
3500
INNOVATE Corp
VATE
$105M
| $777K | ﹤0.01% |
19,518
+248
| +1% | +$10K |
|
Similar funds
Bank of New York Mellon's Q2 2021 Portfolio in Review
As of Q2 2021, Bank of New York Mellon held 4,590 positions worth $517B, up 5.6% from $489B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Bank of New York Mellon's Q2 2021 filing shows 277 new, 1,772 increased, 2,129 reduced and 201 closed positions. Its largest new stake was Organon & Co: 4,240,135 shares worth $128M. The largest sale was Ferguson, an estimated $692M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2021 buy was Organon & Co: 4,240,135 shares worth $128M.
- Bank of New York Mellon added most to Vanguard FTSE Developed Markets ETF in Q2 2021, an estimated $307M increase.
- Bank of New York Mellon's biggest Q2 2021 reduction was Ferguson, cutting an estimated $692M.
- Bank of New York Mellon fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $164M.
- Bank of New York Mellon's ten largest holdings make up 19% of its $517B portfolio in Q2 2021.
- Bank of New York Mellon opened 277 new positions and closed 201 in Q2 2021.
- Bank of New York Mellon's portfolio value rose 5.6% quarter-over-quarter to $517B.
Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.